Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 10, 2020

Study Completion Date

December 31, 2022

Conditions
Ovarian Cancer Stage IIIOvarian Cancer Stage IV
Interventions
DEVICE

PET/CT

"PET/CT (without respiratory gating) is performed on an ad-hoc basis in patients with advanced ovarian cancer in the lead up to surgery. The sensitivity of PET/CT for detecting low volume pleural disease is likely reduced by respiratory motion during the ten minute acquisition time over the chest. By freezing this respiratory motion with respiratory gating, we hope that gated PET/CT detection of pleural metastases will improve over non-gated PET images."

Trial Locations (2)

4029

Royal Brisbane and Women's Hospital, Herston

4101

Mater Health Services, South Brisbane

All Listed Sponsors
collaborator

The University of Queensland

OTHER

collaborator

Royal Brisbane and Women's Hospital

OTHER_GOV

lead

Queensland Centre for Gynaecological Cancer

OTHER_GOV

NCT02258165 - Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter